These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 501901)

  • 1. Inhibition of dog renin activity by pepstatin A.
    Miyazaki M; Komori T; Okunishi H; Toda N
    Jpn Circ J; 1979 Sep; 43(9):818-23. PubMed ID: 501901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human plasma renin activity by pepstatin.
    Guyene TT; Devaux C; Menard J; Corvol P
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1301-6. PubMed ID: 12191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-specific inhibition of pressor agents in vivo by the renin inhibitor pepstatin A.
    Oldham AA; Arnstein MJ; Major JS; Clough DP
    J Hypertens; 1984 Apr; 2(2):157-61. PubMed ID: 6398334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and renin inhibitory properties of a new soluble pepstatin derivative.
    Gardes J; Evin G; Castro B; Corvol P; Menard J
    J Cardiovasc Pharmacol; 1980; 2(5):687-98. PubMed ID: 6157960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble pepstatins: a new approach to blockade in vivo of the renin-angiotensin system.
    Evin G; Gardes J; Kreft C; Castro B; Corvol P; Menard J
    Clin Sci Mol Med Suppl; 1978 Dec; 4():167s-169s. PubMed ID: 282046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin inhibitor and converting enzyme inhibitors suppress vascular angiotensin II.
    Saito H; Nakamaru M; Ogihara T; Rakugi H; Kumahara Y; Shimamoto K; Miyazaki M; Inagami T
    Hypertension; 1989 Jun; 13(6 Pt 2):749-53. PubMed ID: 2661430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressor activity of intracerebroventricularly administered pepstatin in young spontaneously hypertensive rats.
    Tonnaer JA; Versteeg DH; Mens WB; de Jong W
    Clin Exp Hypertens A; 1984; 6(8):1529-42. PubMed ID: 6388914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo inhibition of human and primate renin by a new potent renin inhibitor: SR 42128.
    De Claviere M; Cazaubon C; Lacour C; Nisato D; Gagnol JP; Evin G; Corvol P
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S58-61. PubMed ID: 2412015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New renin inhibitors homologous with pepstatin.
    Eid M; Evin G; Castro B; Menard J; Corvol P
    Biochem J; 1981 Aug; 197(2):465-71. PubMed ID: 7034718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin inhibitory effect of N-acetyl-pepstatin.
    Miyazaki M; Okunishi H; Komori T; Yamamoto K
    Jpn J Pharmacol; 1978 Feb; 28(1):171-4. PubMed ID: 651013
    [No Abstract]   [Full Text] [Related]  

  • 11. Pepstatin analogues as novel renin inhibitors.
    Guégan R; Diaz J; Cazaubon C; Beaumont M; Carlet C; Clément J; Demarne H; Mellet M; Richaud JP; Segondy D
    J Med Chem; 1986 Jul; 29(7):1152-9. PubMed ID: 3543358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibitors. Free-Wilson and correlation analysis of the inhibitory potency of a series of pepstatin analogues on plasma renin.
    Nisato D; Wagnon J; Callet G; Mettefeu D; Assens JL; Plouzane C; Tonnerre B; Pliska V; Fauchère JL
    J Med Chem; 1987 Dec; 30(12):2287-91. PubMed ID: 3316655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pepstatin inhibition of proteinase-free human renin.
    Pourmotabbed G; Chou HJ; Gregerman RI
    Enzyme; 1982; 28(4):343-7. PubMed ID: 6759112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of renin: recent developments.
    Hofbauer KG; Wood JM
    Contrib Nephrol; 1984; 43():144-52. PubMed ID: 6207982
    [No Abstract]   [Full Text] [Related]  

  • 15. Statine-containing renin inhibitor. Dissociation of blood pressure lowering and renin inhibition in sodium-deficient dogs.
    Blaine EH; Schorn TW; Boger J
    Hypertension; 1984; 6(2 Pt 2):I111-8. PubMed ID: 6373590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pepstatin inhibition mechanism.
    Marciniszyn J; Hartsuck JA; Tang J
    Adv Exp Med Biol; 1977; 95():199-210. PubMed ID: 339690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-77: a potent new renin inhibitor. In vitro and in vivo studies.
    Szelke M; Leckie BJ; Tree M; Brown A; Grant J; Hallett A; Hughes M; Jones DM; Lever AF
    Hypertension; 1982; 4(3 Pt 2):59-69. PubMed ID: 7040240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin inhibitory effect of 2-[4-(4'-chlorophenoxy)phenoxyacetylamino]-ethylphosphorylethanolamine (PE-104) in vitro and in vivo.
    Hosoki K; Miyazaki M; Yamamoto K
    J Pharmacol Exp Ther; 1977 Nov; 203(2):485-92. PubMed ID: 909077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma prorenin in humans and dogs. Species differences and further evidence of a systemic activation cascade.
    Wilczynski EA; Osmond DH
    Hypertension; 1983; 5(3):277-85. PubMed ID: 6341216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the renin inhibitor H77 on the pressor responses to injected pig, rat and dog renins in vivo.
    Oldham AA; Arnstein MJ; Major JS; Clough DP
    J Hypertens; 1983 Aug; 1(2):191-5. PubMed ID: 6397517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.